Comparison of the accula sars-cov-2 test with a laboratory-developed assay for detection of sars-cov-2 RNA in clinical nasopharyngeal specimens
Detection Principle
NucleicAcid-PCR based
Target
N gene
Testing Method Category
PCR_KIT
Testing Method
Accula SARS-CoV-2 POCT (Mesa Biotech, Inc., San Diego, CA)
Testing Method - Additional Info
Performances of Accula test (RT-PCR targeting N gene read out on lateral flow) on samples tested with WHO-5 method targeting E gene
Reported Performance
Overall percent agreement: 84.0% ; Positive Percentage Agreement: 68.0% ; Negative Percentage agreement: 100% ; Remarks: Accula test compared to RT-PCR results
Sample Size
100 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements